Roche Diabetes Care Eversense XL presents in Spain, the first implantable device for people with diabetes which marks a milestone in the evolution of these devices. It is the only implantable system that allows you to measure glucose continuously for 6 months12 times more than the rest of the meters available in Europe, without the need to change the sensor every fortnight.
“We are very pleased to be able to bring this advance people living with diabetes. Our goal is to offer comprehensive management of this disease, improving quality of life with solutions adapted to your day-to-day needs”stands out Lisa HuseGeneral Director of Roche Diabetes Care Spain.
The new system is made up of three interconnected elements: a glucose sensora smart transmitter and one mobile app. The sensor is a small capsule, about the size of a pill, that is implanted in the upper arm. The transmitter, which is rechargeable and waterproof, is placed on the sensor. From there data is sent to an application installed on the user’s smartphone that allows viewing the readings in real time.
One of the outstanding characteristics of the system is that the sensor and the transmitter are not physically connected as in the rest of the continuous meters. The transmitter attaches to the surface of the arm and can be removed at any time. When replaced, the transmitter’s battery activates the implanted sensor, which in turn sends data to the transmitter, which calculates glucose values and transfers them via bluetooth to the patient’s smartphone.
In addition, the transmitter has the ability to store recorded values and generate vibrating alerts that the patient may feel in their arm when glucose levels are too high or too low.
Vibration alert for possible hyper or hypoglycemia
The new implantable system has already been tested in 87 patients in 11 hospitals in Spain for 3 months and has achieved high satisfaction from both professionals and patients. The feature most valued by all of them has been its ability to alert the user via vibration when going into hyper or hypoglycemiaallowing you to correct the trend before suffering a serious episode.
Regarding the insertion, which is what worries some patients the most, the specialists affirm that practicing the implant is a very simple, brief and practically painless procedure It doesn’t even require stitches.
According to him Dr. Sorin Ioacarafrom the Elias Emergency University Hospital and the Carol Davila University of Medicine and Pharmacy in Bucharest, “The use of a continuous blood glucose monitoring system represents a turning point to achieve a better control and reduced risk of hypoglycemia. An implant also means less hassle, fewer decisions and more freedom for the patient with diabetes”.
For his part, he Dr. Pablo Abellanan endocrinologist at the Hospital General Universitario de Castellón and professor of Medicine at the CEU, stresses that “this system does not interfere with paracetamol and its vibration alert system represents a very relevant differential advantage over other devices”.
This system guarantees greater adherence to treatment and allows health professionals access to glycemia data collected during 24 hours in the form of a graphical representation.
Another of its main advantages, according to the Dr. María José PicónEndocrinologist at the Virgen de la Victoria Hospital in Malaga, is that “guarantees greater adherence to treatment due to its long-lasting implantable nature. For the health professional it also entails important advantages, such as access to blood glucose data collected for 24 hours in the form of a very useful graphical representation. In this way, the adjustment of the therapy is easier”.
For her part, the Dr. Cintia Gonzálezan endocrinologist at the Hospital de la Santa Creu i Sant Pau in Barcelona, describes this new device as “almost life insurancedue to the function that allows the patient to be warned, through vibration, that he is going to enter hypoglycemia, without the need for him to have the reader nearby or to consult the data on a screen”.
These alerts work even when the patient is asleepwith complete reliability. Users can feel completely safe, because in the event that the glucose level is too high or too low, the transmitter activates a vibrating alert in the arm that wakes you up so you can react and avoid possible nocturnal hypoglycemia.
In fact, this new continuous measurement system guarantees a reliable reading of glucose levels overnight, since sleeping movements that may press the transmitter do not affect the results. And it is that, as the General Director of Spain, “The whole system is designed to obtain excellent control and management of the diseaseimproving the quality of life of people with diabetes”.